Addus HomeCare's (ADUS) "Outperform" Rating Reiterated at Macquarie

Macquarie restated their outperform rating on shares of Addus HomeCare (NASDAQ:ADUS - Free Report) in a report issued on Monday, Benzinga reports. The firm currently has a $139.00 price target on the stock.

A number of other research analysts also recently commented on ADUS. Stephens reiterated an "overweight" rating and issued a $138.00 price objective on shares of Addus HomeCare in a report on Tuesday, August 6th. KeyCorp began coverage on Addus HomeCare in a report on Friday, October 11th. They issued an "overweight" rating and a $150.00 price objective on the stock. StockNews.com downgraded Addus HomeCare from a "strong-buy" rating to a "buy" rating in a report on Sunday, July 7th. Oppenheimer increased their price objective on Addus HomeCare from $140.00 to $145.00 and gave the company an "outperform" rating in a report on Monday, September 23rd. Finally, TD Cowen increased their price objective on Addus HomeCare from $128.00 to $137.00 and gave the company a "buy" rating in a report on Thursday, August 8th. One research analyst has rated the stock with a sell rating, eight have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $131.38.

Addus HomeCare Stock Up 2.1 %

NASDAQ ADUS traded up $2.69 during trading hours on Monday, hitting $128.96. 206,083 shares of the company were exchanged, compared to its average volume of 131,122. The company has a 50 day moving average of $130.02 and a two-hundred day moving average of $120.43. Addus HomeCare has a 52-week low of $81.51 and a 52-week high of $136.12. The firm has a market cap of $2.33 billion, a price-to-earnings ratio of 30.11, a PEG ratio of 2.25 and a beta of 1.04.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last issued its quarterly earnings results on Monday, August 5th. The company reported $1.35 earnings per share for the quarter, topping the consensus estimate of $1.21 by $0.14. Addus HomeCare had a return on equity of 9.81% and a net margin of 6.18%. The company had revenue of $286.90 million for the quarter, compared to the consensus estimate of $284.90 million. During the same quarter in the prior year, the business earned $0.94 EPS. Addus HomeCare's revenue was up 10.4% on a year-over-year basis. On average, equities research analysts predict that Addus HomeCare will post 4.57 EPS for the current year.

Insider Activity at Addus HomeCare

In other Addus HomeCare news, EVP Michael D. Wattenbarger sold 21,917 shares of the firm's stock in a transaction on Monday, August 26th. The stock was sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the completion of the transaction, the executive vice president now owns 7,215 shares of the company's stock, valued at approximately $961,687.35. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. In related news, Director Esteban Lopez sold 500 shares of Addus HomeCare stock in a transaction on Tuesday, September 10th. The stock was sold at an average price of $127.50, for a total value of $63,750.00. Following the transaction, the director now owns 3,366 shares in the company, valued at approximately $429,165. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Michael D. Wattenbarger sold 21,917 shares of Addus HomeCare stock in a transaction on Monday, August 26th. The shares were sold at an average price of $133.29, for a total value of $2,921,316.93. Following the completion of the transaction, the executive vice president now owns 7,215 shares in the company, valued at $961,687.35. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 22,917 shares of company stock valued at $3,050,082 in the last ninety days. Corporate insiders own 4.60% of the company's stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in ADUS. Point72 Asset Management L.P. boosted its holdings in Addus HomeCare by 73.4% in the second quarter. Point72 Asset Management L.P. now owns 745,824 shares of the company's stock valued at $86,598,000 after acquiring an additional 315,602 shares during the last quarter. Millennium Management LLC lifted its stake in shares of Addus HomeCare by 412.7% during the second quarter. Millennium Management LLC now owns 316,418 shares of the company's stock worth $36,739,000 after purchasing an additional 254,705 shares in the last quarter. Boston Partners acquired a new position in shares of Addus HomeCare during the first quarter worth about $12,215,000. Ghisallo Capital Management LLC acquired a new position in shares of Addus HomeCare during the second quarter worth about $11,611,000. Finally, Lord Abbett & CO. LLC acquired a new position in shares of Addus HomeCare during the first quarter worth about $8,274,000. Institutional investors and hedge funds own 95.35% of the company's stock.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.